Genomma Lab Internacional SAB de CV (LABB) Stock Statistics & Valuation Metrics

Genomma Lab Internacional SAB de CV has a market cap or net worth of $14.52B. The enterprise value is $20.09K.

Genomma Lab Internacional SAB de CV has 1,000,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Genomma Lab Internacional SAB de CV’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 12.78%.

The current PE Ratio of Genomma Lab Internacional SAB de CV is 8.5. Genomma Lab Internacional SAB de CV’s PEG ratio is 1.38.

In the last 12 months, Genomma Lab Internacional SAB de CV had revenue of 17.54B and earned 1.61B in profits. Earnings per share was 1.65.

In the last 12 months, operating cash flow was 1.82B and capital expenditures -332.53M, giving a free cash flow of 1.49B billion.

Genomma Lab Internacional SAB de CV pays an annual dividend of ―, resulting in a dividend yield of ―

Genomma Lab Internacional SAB de CV upcoming earnings date is Oct 28, 2026, After Close (Confirmed).

Genomma Lab Internacional SAB de CV as a current ratio of 1.77, with Debt / Equity ratio of 40.36%

In the past 12 months, Genomma Lab Internacional SAB de CV has paid 826.24M in taxes.

Genomma Lab Internacional SAB de CV EV to EBITDA ratio is 6.16, with an EV/FCF ratio of 10.96.

Genomma Lab Internacional SAB de CV has $2.81B in cash and marketable securities with $4.73B in debt, giving a net cash position of -$1.92B billion.

Gross margin is 63.25%, with operating margin of 21.43%, and net profit margin of 9.16%.

The average price target for Genomma Lab Internacional SAB de CV is $16.00, which is 11.43% higher than the current price. The consensus rating is Hold